Think of it like travelling from London to Manchester
If more than 4 days have passed, then skip the missed dose and administer the next dose on the regularly scheduled day
With a proven formulation and regulatory approval, it remains one of the most trusted injectables available in South Korea
The FDA approved liraglutide, the first generic of a once-daily GLP-1 injection, in December 2024
In December 2025, Novo Nordisk received FDA approval for an oral formulation of Wegovy that demonstrated weight loss effects similar to those of the Wegovy injection
Ozempic, Wegovy, Rybelsus, Mounjaro, and Zepbound are registered trademarks of Novo Nordisk A/S and Eli Lilly and Company, respectively